4Chen SC. Cryptococcsis in Australia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B. J Antimicrob Chemother ,2002,49 (S1): S57-61. 被引量：1
5Saag MS,Graybill RJ,Larsen RA,et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis,2000,30(4):710 -718. 被引量：1
6Barchiesi F, Schimizzi AM, Caselli F, et al. Interactions between triazoles and amphotericin B against Cryptococcus neoformans. Antimicrob Agents Chemother, 2000,44 ( 9 ): 2435-2441. 被引量：1
7Li RK, Rinaldi MG. In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole. Antimicrob Agents Chemother,1999,43(6): 1401-1405. 被引量：1
8Stevens DA. Combination immunotherapy and antifungal chemotherapy.Clin Infect Dis, 1998,26(6) :1266 -1269. 被引量：1
9Feldmesser M, Casadevall A. Mechanism of action of antibody to capsular polysaccharide in cryptococcus neoformans infection. Front Biosci, 1998,3:136-151. 被引量：1
10Berg J, Clancy CJ, Nguyen MH. The hidden danger of primary fluconazole prophylaxis for patients with AIDS. Clin Infect Dis, 1998,26( 1 ): 186-187. 被引量：1
